Department of Anesthesiology and Pain Medicine, Gachon University of Medicine and Science Gil Medical Center, Incheon, Korea.
Korean J Anesthesiol. 2011 Jul;61(1):35-41. doi: 10.4097/kjae.2011.61.1.35. Epub 2011 Jul 21.
Plasma levels of N-terminal pro-B-type natriuretic peptide (NT-proBNP) provide useful prognostic predictors in patients after cardiac surgery. However, predictive accuracy of NT-proBNP levels has varied significantly according to renal dysfunction. The purpose of this study was to assess whether preoperative NT-proBNP levels could be used as predictors of early postoperative outcomes on the basis of renal function in patients undergoing off-pump coronary artery bypass surgery (OPCAB).
In 219 patients undergoing elective OPCAB, NT-proBNP and an estimated glomerular filtration rate (eGFR) were assessed preoperatively. All patients were divided into 3 groups according to tertiles of eGFR: the first (eGFR ≥ 90 ml/min/1.73 m(2)), the second (90 ml/min/1.73 m(2) > eGFR ≥ 72 ml/min/1.73 m(2)) and the third tertile group (eGFR < 72 ml/min/1.73 m(2)). End point was the composite of early postoperative complications defined as myocardial infarction, new onset atrial fibrillation, ventricular dysfunction, prolonged mechanical ventilator care (> 48 hr), prolonged ICU stay (≥ 3 days), and in hospital mortality.
There was no difference in early postoperative complications among groups. A preoperative NT-proBNP level of 228 pg/ml and 302 pg/ml (sensitivity 70%, specificity 67%, P < 0.001 and sensitivity 73%, specificity 63%, P = 0.001, respectively) were optimal cut-off values predicting complicated early postoperative course in second and third tertile group, respectively.
Preoperative NT-proBNP levels seem to be predictive of early postoperative complications in patients with eGFR < 90 ml/min/1.73 m(2) undergoing OPCAB.
心脏手术后患者的 N 末端脑利钠肽前体(NT-proBNP)血浆水平提供了有用的预后预测指标。然而,根据肾功能的不同,NT-proBNP 水平的预测准确性差异很大。本研究旨在评估在接受非体外循环冠状动脉旁路移植术(OPCAB)的患者中,基于肾功能的术前 NT-proBNP 水平是否可以作为术后早期结果的预测指标。
在 219 例行择期 OPCAB 的患者中,术前评估了 NT-proBNP 和估算肾小球滤过率(eGFR)。所有患者根据 eGFR 的三分位值分为 3 组:第一组(eGFR≥90ml/min/1.73m²)、第二组(90ml/min/1.73m²>eGFR≥72ml/min/1.73m²)和第三组(eGFR<72ml/min/1.73m²)。终点是术后早期并发症的综合指标,定义为心肌梗死、新发心房颤动、心室功能障碍、机械通气时间延长(>48 小时)、ICU 住院时间延长(≥3 天)和住院死亡率。
各组之间的术后早期并发症无差异。术前 NT-proBNP 水平为 228pg/ml 和 302pg/ml(敏感性 70%,特异性 67%,P<0.001 和敏感性 73%,特异性 63%,P=0.001)分别为预测第二和第三组复杂术后早期病程的最佳截断值。
对于接受 OPCAB 的 eGFR<90ml/min/1.73m²的患者,术前 NT-proBNP 水平似乎可以预测术后早期并发症。